Clarivate agrees to sell Life Sciences and Healthcare business to Altaris affiliate for $600 million

CCC Intelligent Solutions Holdings Inc
Clarivate PLC

CCC Intelligent Solutions Holdings Inc

CCC

0.00

Clarivate PLC

CLVT

0.00

  • Clarivate agreed to sell its Life Sciences and Healthcare business to an Altaris affiliate for USD 600 million.
  • Consideration includes USD 500 million cash at closing, USD 25 million deferred payment due no later than Jan. 31, 2028, and a USD 75 million unsecured senior note at closing.
  • Closing targeted by end-2026, subject to regulatory clearances and other customary conditions; no shareholder vote required.
  • Buyer arranged equity and debt financing; Altaris funds guaranteed a USD 33 million termination fee in certain scenarios.
  • Either party can terminate if the deal is not completed by March 3, 2027, subject to specified conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clarivate plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-26-010269), on July 06, 2026, and is solely responsible for the information contained therein.